Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E.R. Parra, M.L. Costardi, V. Capelozzi (Sao Paulo, Brazil). Idiopathic pulmonary fibrosis: Clinical, radiological and functional significance of biomarkers of proliferation. Eur Respir J 2012; 40: Suppl. 56, 713

Member's Comments

No comment yet.

Related content which might interest you: Clinical significance of combined pulmonary fibrosis and emphysema Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Idiopathic pulmonary fibrosis: classification, epidemiology, course and prognosis Source: International Congress 2016 – Russia Session Year: 2016 Clinical and radiological variants of fibrosis pulmonary sarcoidosis Source: Virtual Congress 2020 – Clinical issues in granulomatous lung diseases Year: 2020 Distinct clinical and pathological phenotypes in IPF Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 New radiological diagnostic criteria: impact on idiopathic pulmonary fibrosis diagnosis Source: Eur Respir J, 54 (5) 1900905; 10.1183/13993003.00905-2019 Year: 2019 Idiopathic pulmonary fibrosis: approaches to diagnostic Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Clinical course of idiopathic pulmonary fibrosis (IPF): Prediction and outcome Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Idiopathic pulmonary fibrosis phenotypes: Identification of new clinico-pathological stigmata Source: Annual Congress 2010 - Clinical issues in idiopathic pulmonary fibrosis Year: 2010 Clinical features of combined pulmonary fibrosis and emphysema Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Correlation of a progression of fibrotic changes in idiopathic pulmonary fibrosis 1 year after a diagnosis with initial functional and immunologic parameters Source: Eur Respir J 2004; 24: Suppl. 48, 667s Year: 2004 Idiopathic pulmonary fibrosis (IPF): epidemiology, biology, diagnosis and treatment Source: Virtual Congress 2020 – When the lung gets stiff Year: 2020 Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Clinical significance of autoantibody screening in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Dyspnoea: a prognostic marker for idiopathic pulmonary fibrosis Source: Eur Respir J 2011; 37: 476 Year: 2011 Functional and prognostic effects when emphysema complicates idiopathic pulmonary fibrosis Source: Eur Respir J, 50 (1) 1700379; 10.1183/13993003.00379-2017 Year: 2017 Prognostic evaluation in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011